This IND clearance marks a significant milestone for Hinge Bio and our mission to develop innovative therapies to improve the lives of patients suffering from Lupus and other B cell-mediated diseases ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to UB-VV111 for the treatment of ...

Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain ...

Immusoft of CA, a clinical stage, engineered B cell company, today announced a historic achievement: the safe and well-tolerated re-dosing of a patient with a gene modified therapeutic product ...

The next time you crave a sweet treat, go ahead and buy a bag of jellybeans—guilt free. Your indulgence will be in the ...

The Nobel Prize in Medicine was awarded on Monday to three scientists for discovering how a particular kind of cell can stop ...

Investor reaction to the deal was muted, with BMO Capital Markets analysts saying they "continue to look for more" from ...

By examining genomic variation more closely, scientists can now identify new disease connections with greater speed and accuracy. For centuries, scientists have recognized that certain illnesses can ...

His work in the manipulation of cells laid the foundation for stem cell biology and regenerative medicine and led to the ...

Research from the National Institutes of Health shows that wind can aid in increasing pain for sickle cell patients, primarily because of the way their blood cells are shaped. The NIH found that ...

Novo Nordisk (NVO) stock is in focus as the company is closing its cell therapy unit amid a global restructuring effort ...